TY - JOUR T1 - Appointment and medication non-adherence is associated with increased mortality in insulin-treated type 2 diabetes JF - Evidence Based Medicine JO - Evid Based Med SP - 112 LP - 113 DO - 10.1136/eb-2012-100912 VL - 18 IS - 3 AU - Lindsay Bundrick Harrison AU - Ildiko Lingvay Y1 - 2013/06/01 UR - http://ebm.bmj.com/content/18/3/112.abstract N2 - Commentary on: Currie CJ, Peyrot M, Morgan CL, et al. The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care 2012; 35: 1279– 84.OpenUrlAbstract/FREE Full Text Diabetes increases the risk of death twofold; identifying novel modifiable risk factors could improve patient outcomes and focus healthcare spending in areas with the highest return. Non-adherence to prescribed medications and clinic appointments may be independent risk factors for excess mortality. Currie and colleagues performed a database review of insulin-treated patients with type 2 diabetes who followed up for 6 months prior to insulin initiation and at least 30 months post-insulin initiation during which compliance with any medications and appointments were evaluated. Mortality was assessed from the end of 36 months (index date) which fell between 2000 and 2009. Information from 15 984 charts was collected until death or … ER -